APDN Financials 07/16/2014 09:35:29 Applied DNA S

APDN Financials 07/16/2014 09:35:29
Applied DNA Sciences, Inc.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue 2,036 1,855 969 520
Cost of Revenue - - - -
Gross Profit 2,036 1,855 969 520
Operating Expenses
Research and Development 692 433 269 76
Sales, General and Admin. 11,199 7,616 8,389 7,189
Non-Recurring Items - - - -
Other 321 314 368 372
Operating Income (10,176) (6,508) (8,056) (7,117)
Income From Continuing Operations
Add'l Income/Expense Items (7,512) - - -
Earnings Before Interest and Tax (17,686) (7,151) (8,056) (7,910)
Interest Expense - - 2,459 -
Earnings Before Tax (17,686) (7,151) (10,515) (7,910)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (17,686) (7,151) (10,515) (7,910)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (17,686) (7,151) (10,515) (7,910)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (17,686) (7,151) (10,515) (7,910)